ICARES Medicus (ROCO:6612) Other Current Payables: NT$142 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6612 ICARES Medicus Inc ROCO:6612
84 GF Score
Price NT$70.10
GF Value NT$171.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ICARES Medicus Other Current Payables?

ICARES Medicus ROCO:6612 +0.43% 84 Other Current Payables is NT$142 Mil as of Mar. 2026. GuruFocus rates ROCO:6612 with a GF Score™ of 84/100 and a GF Value™ of NT$171.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

ICARES Medicus's Other Current Payables for the quarter that ended in Mar. 2026 was NT$142 Mil.

ICARES Medicus's quarterly Other Current Payables declined from Sep. 2025 (NT$132 Mil) to Dec. 2025 (NT$132 Mil) but then increased from Dec. 2025 (NT$132 Mil) to Mar. 2026 (NT$142 Mil).

ICARES Medicus's annual Other Current Payables increased from Dec. 2023 (NT$93 Mil) to Dec. 2024 (NT$110 Mil) and increased from Dec. 2024 (NT$110 Mil) to Dec. 2025 (NT$132 Mil).

ICARES Medicus Other Current Payables Related Terms

ICARES Medicus Other Current Payables Historical Data

* Premium members only.

The historical data trend for ICARES Medicus's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICARES Medicus Other Current Payables Chart

ICARES Medicus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.56 73.02 93.23 109.66 131.51

ICARES Medicus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 131.49 136.62 132.30 131.51 141.89
ROCO:6612
84GF Score
ICARES Medicus Inc ROCO:6612
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ICARES Medicus Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$142 Mil mean?
ICARES Medicus (ROCO:6612) has a Other Current Payables of NT$142 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on ICARES Medicus and its competitors.
Is ICARES Medicus' Other Current Payables too high?
ICARES Medicus' current Other Current Payables is NT$142 Mil. Overall, ICARES Medicus has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' Other Current Payables compare to ISRG and BDX?
ICARES Medicus' Other Current Payables of NT$142 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on ICARES Medicus and its competitors. ICARES Medicus's current Other Current Payables is NT$142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Possible Value Trap. The stock's GF Value™ is NT$171.39, compared to a current price of NT$70.10 — trading 59.1% below its estimated fair value. The current Other Current Payables is NT$142 Mil. ICARES Medicus' overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current Other Current Payables is NT$142 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$70.10 is trading 59.1% below its estimated GF Value™ of NT$171.39. GuruFocus considers ICARES Medicus to be Possible Value Trap.

Key valuation signals for ROCO:6612:

  • Other Current Payables: NT$142 Mil
  • GF Value™: NT$171.39 vs. price of NT$70.10 (59.1% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ICARES Medicus Business Description

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
84GF Score

Get the complete analysis for ROCO:6612

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.10
Price
NT$171.39
GF Value